I always viewed the Mexico trial as a backup. There's a pattern to these things if you have been with CYDY for awhile. Remember the deal with a Chinese company? The head to head with Remdesivir? How about numerous non-binding term sheets? Revenue 2019? We have accomplished a lot in the last year, but there have been quite a few statements made about the business that were unlikely to ever happen. When they talk about the science, I listen, particularly when it is the scientists talking. When they talk about running the business/starting 14 trials, I take it with a spoonful of salt.